Therapy of Chronic Cold Agglutinin Disease With Eculizumab
Therapy for Chronic Cold Agglutinin Disease
|3||Active, not recruiting||
Short Course of Bortezomib in Anemic Patients With Refractory Cold Agglutinin Disease
Bendamustine and Rituximab Combination Therapy for Cold Agglutinin Disease
Safety, Tolerability and Activity of TNT009 in Healthy Volunteers and Patients With Complement Mediated Disorders
The RITAI Cohort: An Observational Study on Rituximab Off-label Use for Auto-immune Disorders
† Study has passed its completion date and status has not been verified in more than two years.